Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $53.2350 (-1.12%) ($53.2350 - $53.2350) on Wed. Nov. 16, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.31% (three month average) | RSI | 72 | Latest Price | $53.2350(-1.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.3% a day on average for past five trading days. | Weekly Trend | HALO advances 6.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(37%) IFRA(32%) IWM(31%) IWO(31%) IWN(30%) | Factors Impacting HALO price | HALO will decline at least -1.155% in a week (0% probabilities). VIXM(-9%) VXX(-6%) XBI(-4%) XME(-2%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.155% (StdDev 2.31%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $53.67(-0.81%) | 10 Day Moving Average | $50.55(5.31%) | 20 Day Moving Average | $48.81(9.07%) | To recent high | -1.5% | To recent low | 38.2% | Market Cap | $7.276b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |